KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Debt Ratio (2017 - 2025)

Aquestive Therapeutics (AQST) has 8 years of Debt Ratio data on record, last reported at 0.23 in Q4 2025.

  • For Q4 2025, Debt Ratio fell 27.08% year-over-year to 0.23; the TTM value through Dec 2025 reached 0.23, down 27.08%, while the annual FY2025 figure was 0.23, 27.08% down from the prior year.
  • Debt Ratio reached 0.23 in Q4 2025 per AQST's latest filing, up from 0.22 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.02 in Q3 2022 and bottomed at 0.12 in Q1 2024.
  • Average Debt Ratio over 5 years is 0.54, with a median of 0.48 recorded in 2023.
  • Peak YoY movement for Debt Ratio: tumbled 81.98% in 2024, then soared 165.07% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.86 in 2021, then grew by 5.73% to 0.91 in 2022, then crashed by 47.53% to 0.48 in 2023, then tumbled by 33.11% to 0.32 in 2024, then dropped by 27.08% to 0.23 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.23 in Q4 2025, 0.22 in Q3 2025, and 0.37 in Q2 2025.